Register now for MPE’s webinar on Evidence-Based Patient AdvocacyMPE, Patient evidence19 October 2020
ASCO and EHA highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, MPE, Myeloma, Videos20 July 2020
EHA 2020 – Subcutaneous daratumumab shows improved clinical outcomes in AL amyloidosisAL amyloidosis14 June 2020
FDA Refusal to File letter for Idecabtagene Vicleucel (ide-cel, bb2121) for the treatment of myeloma patientsAccess, Myeloma14 May 2020
MPE webinar on the impact of myeloma and AL amyloidosis in carers. What are the issues and challenges?AL amyloidosis, MPE, Myeloma8 May 2020
